Laurus Labs controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2021
Merck files Januvia patent suit against Laurus
Lawsuit filed
Merck Sharp & Dohme Corp. filed a patent suit in the District of Delaware against Laurus Labs Limited and Laurus Generics Inc. after the defendants submitted an ANDA to the FDA seeking to produce a generic version of Januvia. Merck is seeking a declaration of patent infringement; the filing describes the alleged infringement, not a court determination.
Source excerpt
Merck is seeking declaratory judgement of patent infringement after the defendants submitted an Abbreviated New Drug Application (ANDA) to the Food and Drug Administration (FDA) to produce a generic version of the plaintiff’s diabetes treatment.
A patent suit was filed on Thursday in the District of Delaware by Merck Sharp & Dohme Corp. against Laurus Labs Limited and Laurus Generics Inc..